Using voice technology to improve post-surgery care for gastrointestinal cancer patients
Official title: REmote Symptom COllection to improVE postopeRative Care
Run by Medstar Health Research Institute · NCT06190730 · Data updated 2026-11-12
This study is testing whether a voice technology system can help improve the recovery and care of patients after surgery for gastrointestinal cancer compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 281 (estimated) |
| Sponsor | Medstar Health Research Institute Academic / other |
| Locations | 2 sites (Baltimore, Maryland and 1 other locations) |
| Status | Recruiting |
| Started | July 23, 2024 |
| Main results expected | September 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 3, 2025 |
| Trial ID | NCT06190730 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are scheduled for gastrointestinal surgery and can communicate in English.
✕Probably not a fit
Patients who are unable to provide informed consent or have a life expectancy of less than 60 days may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of a Voice-Assisted Remote Symptom Monitoring System (VARSMS) to enhance post-operative care for patients who have undergone surgery for malignant gastrointestinal tumors. It is a randomized controlled trial where participants will be assigned to either use the VARSMS or receive standard care. The goal is to address vulnerabilities in the transition of care after discharge by providing a technological solution for symptom monitoring. The study will assess the impact of this intervention on patient outcomes and satisfaction.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of post-operative care and patient outcomes for those recovering from gastrointestinal cancer surgery.
How similar studies have gone: Other studies utilizing remote monitoring technologies have shown promise in improving patient outcomes, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. At least 18 years old. Ages of subjects \>89 will simply be reported as \>90. 2. Scheduled for a GI surgery for management of a tumor in a participating hospital. 3. Fluent in oral and written English. 4. Has consistent and continued full access to an operational Wi-Fi for the duration of the study. Exclusion criteria 1. Unable to provide informed consent. 2. Not willing to commit to regular participation in the study to include daily use (40 days) of the study application. 3. Life expectancy of less than 60 days. 4. In the opinion of the investigator, participation in this study is contraindicated.
Where it's running
-
MedStar Health
Baltimore, Maryland, United States Recruiting -
Creighton University
Omaha, Nebraska, United States Recruiting
Study contacts
- Study coordinator: Nawar Shara, PhD
- Email: nawar.shara@medstar.net
- Phone: 301-502-0339
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing two methods for examining gastrointestinal lesions
This study is testing whether a new imaging system for examining gastrointestinal lesions works better than the standard method for people undergoing endoscopic ultrasound.
-
Frailty before GI cancer surgery: does frailty predict post-op outcomes in older adults?
This study tests whether frailty measured before surgery can predict complications and recovery in patients 60 and older undergoing elective gastrointestinal cancer surgery.
-
Biological Collection to Help Create Models for Digestive Cancers and IBD
Researchers are gathering tissue and biological samples from patients with inflammatory bowel disease or digestive cancers to build personalized models and test new therapies.
-
See if a leg raise before anesthesia helps predict low blood pressure after induction in GI tumor surgery
This study tests whether a passive leg raise, measured with carotid Doppler, can predict post-induction hypotension in adults undergoing elective gastrointestinal tumor surgery.
-
SI-B036 in advanced gastrointestinal and other solid tumors
This phase 1 trial tests SI-B036 to see if it is safe and tolerable in adults with locally advanced or metastatic gastrointestinal and other solid tumors.
-
Blood extracellular vesicles to detect chemotherapy-related nerve damage.
We will test whether tiny blood particles called extracellular vesicles can predict who will develop chemotherapy-induced peripheral neuropathy in adults receiving taxane, platinum, or antimitotic chemotherapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.